Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             191 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (towne) in humans Adler, Stuart
1999
12 2 p. 163-
1 p.
artikel
2 A case report on five patients developing CMV retinitis after bone marrow transplantation Larsson, Kajsa
1999
12 2 p. 148-
1 p.
artikel
3 A comparison of flow cytometry with slide method to detect pp65-antigenemia during active CMV infection Imbert-Marcille, Berthe-Marie
1999
12 2 p. 180-
1 p.
artikel
4 Active human cytomegalovirus infection during chronic infection by hepatitis B and delta viruses Ghisetti, Valeria
1999
12 2 p. 173-
1 p.
artikel
5 Additional inflammatory respons in cytomegalovirus infected kidney allograft recipients leads to acceleration into chronic rejection Kloover, Jeroen
1999
12 2 p. 145-
1 p.
artikel
6 Allogeneic transplantation of latently infected kidneys induces expression of MCMV lytic replication cycle genes in vivo Hummel, Mary
1999
12 2 p. 99-
1 p.
artikel
7 Altered expression of genes encoding extracellular matrix proteins in cells infected with human cytomegalovirus Schaarschmidt, Peter
1999
12 2 p. 127-
1 p.
artikel
8 Altered patterns of cellular gene expression in human cytomegalovirus pp71 producing fibroblasts Bentham, Matthew
1999
12 2 p. 97-
1 p.
artikel
9 Analysis of NK cell mediated lysis of CMV-infected cells Fletcher, Jean
1999
12 2 p. 142-
1 p.
artikel
10 Analysis of TCR clonotypes of CTL specific for HIV and for human cytomegalovirus (HCMV) in advancing HIV infection Sissons, Patrick
1999
12 2 p. 150-
1 p.
artikel
11 A new 6-amino-quinolone compound with anti-HCMV activity Palù, Giorgio
1999
12 2 p. 112-
1 p.
artikel
12 Anti-cytomegalovirus (CMV) IgG avidity and/or immunoblotting for anti-CMV IgM to identify pregnant women at risk of transmitting congenital CMV infection Lazzarotto, Tiziana
1999
12 2 p. 184-
1 p.
artikel
13 Assembly of complexes of class I MHC protein with the m4 protein of murine cytomegalovirus Kavanagh, Daniel
1999
12 2 p. 131-
1 p.
artikel
14 Assessing the time of first onset of viremia, antigenemia, and dnaemia and the time to clearing during ganciclovir therapy fascilitates prediction of cytomegalovirus (CMV) disease vs. CMV syndrome in renal allograft recipients Schäfer, Peter
1999
12 2 p. 177-
1 p.
artikel
15 Associated cytomegalovirus (CMV) infection in oncohaematological patients Tchebotkevitch, Vitali
1999
12 2 p. 181-
1 p.
artikel
16 Associations of full-length and truncated HCMV helicase-primase proteins McMahon, Timothy
1999
12 2 p. 100-
1 p.
artikel
17 Atherosclerotic lesions in the aorta after MCMV infection, increased hystopathology after dual infection with MCMV and chlamydia pneumoniae Gonczol, Eva
1999
12 2 p. 156-
1 p.
artikel
18 Attempts to complement HCMV ie2 null mutants in human fibroblast lines Greaves, Richard
1999
12 2 p. 125-
1 p.
artikel
19 A very rapid CMV pp65 antigenemia assay. Evaluation of the CMV Brite™ TURBO kit Schilizzi, Bridget
1999
12 2 p. 105-
1 p.
artikel
20 Both desferioxamine (DFO) and calcium-trinatrium-diethylenetriamine pentaacetic acid (DTPA) have an antiviral effect in vitro but a limited effect in vivo against rat cytomegalovirus Kloover, Jeroen
1999
12 2 p. 183-
1 p.
artikel
21 Breast-feeding and the risk of postnatal CMV-transmission to preterm infants Hamprecht, Klaus
1999
12 2 p. 105-
1 p.
artikel
22 Canarypox-CMV-pp65 recombinant immunization of seronegative subjects elicits pp65 specific CTL precursors with a frequency comparable to that of naturally seropositive individuals Gyulai, Zsofia
1999
12 2 p. 164-
1 p.
artikel
23 Cell DNA replication in HCMV infected cells Jeor, Stephen S.T.
1999
12 2 p. 124-
1 p.
artikel
24 Chairman's welcome Borysiewciz, Lesley K.
1999
12 2 p. 75-
1 p.
artikel
25 Changes in the risk for cytomegalovirus (CMV) infection and disease in patients (pts) after allogeneic stem cell transplantation (SCT) Reusser, Pierre
1999
12 2 p. 185-
1 p.
artikel
26 Characterization of a novel tegument protein of HCMV: pUL25 Landini, Maria Paola
1999
12 2 p. 115-
1 p.
artikel
27 Characterization of cytomegalovirus strain circulation Bale, James
1999
12 2 p. 178-
1 p.
artikel
28 Characterization of the DNA sequence of the rat cytomegalovirus genome Beuken, Erik
1999
12 2 p. 101-
1 p.
artikel
29 Cloning of the human cytomegalovirus genome as an infectious bacterial artificial chromosome Hahn, Gabriele
1999
12 2 p. 164-
1 p.
artikel
30 CMV DNA in blood and CSF Stanojevic, Maja
1999
12 2 p. 107-
1 p.
artikel
31 CMV DNA replication: Formation of replication compartments and the role of accessory proteins IE1, IE2, UL84 and PML Ahn, J.-H.
1999
12 2 p. 86-
1 p.
artikel
32 CMV pp 65 antigenemia detection — 1 year experience Brichacek, Petr
1999
12 2 p. 140-
1 p.
artikel
33 CMV retinitis in an HIV-infected patient on prolonged and effective highly active antiretroviral therapy (HAART) Weinberg, Adriana
1999
12 2 p. 143-
1 p.
artikel
34 CMV-specific T helper precursor frequencies (PCMV) in HIV patients treated with highly active antiretroviral therapy (HAART) with and without pre-existing CMV retinitis Boeckh, Micheal
1999
12 2 p. 138-
1 p.
artikel
35 Combination of ganciclovir plus foscarnet for CMV pre-emptive therapy in allogeneic BMT Geretti, Anna
1999
12 2 p. 176-
1 p.
artikel
36 Comparison of different quantitative cytomegalovirus (CMV) DNA assays and a CMV mRNA assay in allogeneic stem cell transplant (SCT) patients Lewensohn-Fuchs, Ilona
1999
12 2 p. 132-
1 p.
artikel
37 Comparison of plasma PCR and pp65 antigenemia assay in the quantification of CMV in transplant patients Piiparinen, Heli
1999
12 2 p. 169-
1 p.
artikel
38 CTL epitope as an immunotherapeutic strategy against CMV infection Diamond, Don
1999
12 2 p. 165-
1 p.
artikel
39 Cytomegalic endothelial cells (CEC) and non-infected endothelial cells in peripheral blood of transplant patients with cytomegalovirus infections Kas-Deelen, Diane
1999
12 2 p. 154-
1 p.
artikel
40 Cytomegalovirus infection detected by polimerase chain reaction (PCR) and pp65 detection in HIV positive patients with peripheral neurological syndromes Nascimento, Cláudia
1999
12 2 p. 183-
1 p.
artikel
41 Cytomegalovirus infections in non-immunosuppressed critically ill surgical patients: An occult epidemic Cook, Charles
1999
12 2 p. 151-
1 p.
artikel
42 Cytomegalovirus-specific T lymphocytes: studies in normal volunteers and subjects infected with HIV-1 Denis, Michel
1999
12 2 p. 145-
1 p.
artikel
43 Cytomegalovirus stimulates the expression of cellular enzymes involved in nucleotides biosynthesis Lembo, David
1999
12 2 p. 110-
1 p.
artikel
44 Decrease in CMV replication in HIV infected patients after treatment with highly active antiretroviral treatment (HAART) O'Sullivan, Cathal
1999
12 2 p. 149-
1 p.
artikel
45 Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain Vink, Cornelis
1999
12 2 p. 125-
1 p.
artikel
46 Desferrioxamine (DFO) inhibits rat CMV) (RCMV) replication and associated inflammatory changes in rat liver allografts Martelius, Timi
1999
12 2 p. 169-
1 p.
artikel
47 Detection of DNA sequences of various herpesviruses and chlamydia pneumoniae in human atherosclerotic plaques Virok, Dezso
1999
12 2 p. 156-
1 p.
artikel
48 Detection of viral mRNAs as a diagnostic tool for CMV infection in humans Sillekens, Peter
1999
12 2 p. 174-
1 p.
artikel
49 Developmental susceptibility of fetal brain to intrauterine rhesus CMV infection Lockridge, Kristen
1999
12 2 p. 161-
1 p.
artikel
50 Development of human cytomegalovirus (HCMV) antiviral resistance in lung transplant recipients with long-term antiviral therapy Lurain, Nell
1999
12 2 p. 111-
1 p.
artikel
51 Development of resistant CMV strains after foscavir or ganciclovir therapy in kidney allograft recipients Hökeberg, Ingegerd
1999
12 2 p. 179-
1 p.
artikel
52 Dexamethasone increased cytomegalovirus infection of human macrophages (THP-1) Aldebert, Delphine
1999
12 2 p. 117-
1 p.
artikel
53 Diagnostic and prognostic value of human cytomegalovirus (HCMV) load and IgM antibody in blood of fetuses and newborns with congenital HCMV infection Simoncini, Lavinia
1999
12 2 p. 175-
1 p.
artikel
54 Different mechanisms for downregulation of HLA class II molecules at IE and late times after HCMV infection in macrophages Odeberg, Jenny
1999
12 2 p. 121-
1 p.
artikel
55 Direct quantification of human cytomegalovirus (HCMV) immediate early and late mRNA levels in the blood of HCMV-infected individuals using competetive NASBA Middeldorp, Jaap
1999
12 2 p. 103-
1 p.
artikel
56 Distinct, longitudinal localization patterns of RhCMV in the spleen following experimental inoculation of rhesus macaques Barry, Peter
1999
12 2 p. 94-
1 p.
artikel
57 DNA microarrays of human cytomegalovirus genome: Profiling kinetic class with drug sensitivity of viral gene expression Ghazal, Peter
1999
12 2 p. 120-
1 p.
artikel
58 Down-regulation of the chemokine RANTES during human cytomegalovirus infection of endothelial cells Billstrom, Marcella (Sally)
1999
12 2 p. 128-
1 p.
artikel
59 Drug resistant cytomegalovirus infection in children after stem cell transplantation Prix, Lothar
1999
12 2 p. 182-
1 p.
artikel
60 Dynamics of the immune response during cytomegalovirus diseases Reschke, Marco
1999
12 2 p. 133-
1 p.
artikel
61 Early detection of active cytomegalovirus infection in heart/lung trans plant recipients Bruggeman, Cathrien
1999
12 2 p. 122-
1 p.
artikel
62 Early detection of cytomegalovirus in renal transplant recipients: Additional value of PCR and NASBA Goossens, Valère
1999
12 2 p. 100-
1 p.
artikel
63 Early results of treatment of symptomatic congenital cytomegalovirus infection Idzik, Miroslawa
1999
12 2 p. 171-
1 p.
artikel
64 Effect of hAPN-CD13 expressed in U373-MG cells on CMV infection Zaia, John
1999
12 2 p. 122-
1 p.
artikel
65 Effect of human cytomegalovirus infection on apoptosis and expression of bcl-2 and Fas mRNA Dong, Yongsui
1999
12 2 p. 160-
1 p.
artikel
66 Effects of cytomegalovirus infection and prolonged cold ischemia on chronic rejection of rat renal allografts Van Dam, Joanne
1999
12 2 p. 137-
1 p.
artikel
67 Effects of histone deacetylases on human cytomegalovirus infection Murphy, Jane
1999
12 2 p. 123-
1 p.
artikel
68 Efficacy and safety of valaciclovir as prophylaxis against CMV infection and disease in BMT recipients Ljungman, Per
1999
12 2 p. 167-
1 p.
artikel
69 Efficient control of in vitro HCMV infection mediated by specific recognition of infected antigen presenting cells (APC) by anti-IE1 CD4+ T cell clones Davignon, Jean-Luc
1999
12 2 p. 134-
1 p.
artikel
70 Elimination of CD13 positive cells — an approach to prevent transmission of HCMV in bone marrow transplantation Feld, Sari
1999
12 2 p. 175-
1 p.
artikel
71 Elimination of donor-specific alloreactivity by bone marrow chimerism prevents cytomegalovirus accelerated transplant vascular sclerosis in rat small bowel transplants Orloff, Susan
1999
12 2 p. 142-
1 p.
artikel
72 Emergence of UL97 mutations in AIDS patients with CMV infection before or after the introduction of highly active antiretroviral therapy (HAART) Marenzi, Roberta
1999
12 2 p. 170-
1 p.
artikel
73 Endothelial cell tropism of HCMV isolates is determined by the efficiency of nuclear translocation of viral DNA Sinzger, Christian
1999
12 2 p. 154-
1 p.
artikel
74 Escape from HLA-DR restricted anti-human cytomegalovirus CD4+ T cell response is mediated by immediate early repression of IFN-gamma-induced CIITA expression Roy, Emmanuelle
1999
12 2 p. 144-
1 p.
artikel
75 Evaluation of a new CMV plasma quantitative test in AIDS patients: COBAS AMPLICOR CMV MONITOR compared with pp65 Ag and AMPLICOR CMV Pellegrin, Isabelle
1999
12 2 p. 113-
1 p.
artikel
76 Evaluation of cobas amplicor CMV monitor for the detection and quantification of cytomegalovirus Zweygberg Wirgart, Benita
1999
12 2 p. 176-
1 p.
artikel
77 Evaluation of new quantitative assays: Cobas amplicor CMV monitor (Roche Diagnostics) in plasma and bDNA CMV 2.0 (Chiron Corporation) in PBLs for diagnosis of CMV disease during follow-up of aids patients Pellegrin, Isabelle
1999
12 2 p. 98-
1 p.
artikel
78 Evaluation of the nuclisens CMV pp67 assay for detection of cytomegalovirus infection after allogeneic stem cell transplantation Einsele, Hermann
1999
12 2 p. 172-
1 p.
artikel
79 Evidence that human cytomegalovirus DNA cleavage involves a cellular DNA polymerase McVoy, Michael
1999
12 2 p. 94-
1 p.
artikel
80 Expression of TGF-B and PDGF-AA antigens after CMV infection in transplanted rat kidney Holma, Kaisa
1999
12 2 p. 158-
1 p.
artikel
81 Functional interaction of HCMV immediate-early 2 protein and hTAFII130/135 Caswell, Richard
1999
12 2 p. 124-
1 p.
artikel
82 Functions of glycoprotein B Compton, Teresa
1999
12 2 p. 87-
1 p.
artikel
83 General information 1999
12 2 p. 76-
1 p.
artikel
84 Generation of specific T cell clones against human cytomegalovirus immediate-early (IE-1) and pp65 recombinant proteins expressed by autologous B lymphoblastoid cell lines Retière, Christelle
1999
12 2 p. 147-
1 p.
artikel
85 Genetic analysis of an aciclovir-resistant murine cytomegalovirus mutant Minematsu, Toshio
1999
12 2 p. 110-
1 p.
artikel
86 Genomic organisation of human natural killer cell receptor genes Barten, R.
1999
12 2 p. 89-
1 p.
artikel
87 G-protein coupled receptors (GPCR) Michelson, Susan
1999
12 2 p. 88-
1 p.
artikel
88 Growth phenotypes of cytomegalovirus isolated do not correlate with susceptibility to foscarnet or ganciclovir Mousavi-Jazi, Mehrdad
1999
12 2 p. 118-
1 p.
artikel
89 HCMV delayed-early gene activity in the absence of IE1 Gawn, Jonathan
1999
12 2 p. 104-
1 p.
artikel
90 HCMV infection sensitises fibroblasts to fas- and TNFa-mediated apoptosis and induces a modulation of FLIP/casper isoforms transcription Alam, Antoine
1999
12 2 p. 127-
1 p.
artikel
91 HCMV UL97 genetics: UL97 kinase activity is required for efficient DNA replication and late gene expression Jones, Thomas
1999
12 2 p. 112-
1 p.
artikel
92 Herpesvirus replication and the nucleus Everett, Roger
1999
12 2 p. 88-
1 p.
artikel
93 High incidence of CMV reactivation in blood and lung of surgical intensive care patients Jahn, Gerhard
1999
12 2 p. 102-
1 p.
artikel
94 HLA-haplotypes presenting the major CTL-inducing HCMV proteins Endresz, Valeria
1999
12 2 p. 139-
1 p.
artikel
95 Human CMV infection of differentiating cytotrophoblasts impairs invasion competence in vitro: A possible explanation for CMV-related pregnancy complications Pereira, Lenore
1999
12 2 p. 160-
1 p.
artikel
96 Human cytomegalovirus blocks interferon_gamma stimulate upregulation of MHC class I expression and the class I antigen processing machinery Miller, Daniel
1999
12 2 p. 151-
1 p.
artikel
97 Human cytomegalovirus disrupts constitutive MHC class II expression Cebulla, Colleen
1999
12 2 p. 117-
1 p.
artikel
98 Human cytomegalovirus does not replicate in polymorphomuclear leukocytes harboring infectious virus and viral pp65, DNA and mRNAs Gerna, Giuseppe
1999
12 2 p. 93-
1 p.
artikel
99 Human cytomegalovirus down-regulates the expression of class II molecules of major histocompatibility complex Sánchez-Cruz, Pedro
1999
12 2 p. 118-
1 p.
artikel
100 Human cytomegalovirus enters retinal pigment epithelial and endothelial cells by endocytosis Bodaghi, Bahram
1999
12 2 p. 126-
1 p.
artikel
101 Human cytomegalovirus (HCMV) infection in children with systemic lupus erythematosus (SLE) Zhang, Changpin
1999
12 2 p. 106-
1 p.
artikel
102 Human cytomegalovirus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhigh CD8+ T cells comprise both naive and memory cells Wills, Mark
1999
12 2 p. 135-
1 p.
artikel
103 Human herpesvirus 6 infection inhibits cytomegalovirus-specific T-cell immunity in recipients of allogeneic hematopoietic stem cell transplants Fu-Zhang, Wang
1999
12 2 p. 150-
1 p.
artikel
104 Human kidney artery organ culture system for studying the pathogenesis of human cytomegalovirus infection Mertens, Thomas
1999
12 2 p. 153-
1 p.
artikel
105 Identification of CD8-T-cell epitopes in the non-structural HCMV major immediate early protein Kern, Florian
1999
12 2 p. 149-
1 p.
artikel
106 Immunolgical predictive factors for CMV disease Nordøy, Ingvild
1999
12 2 p. 136-
1 p.
artikel
107 Immunomodulation of cytomegalovirus-induced myocarditis: NK1.1_+ cells prevent disease while T cells and lipopolysaccharide promote disease Shellam, Geoffrey
1999
12 2 p. 159-
1 p.
artikel
108 Implication of gamma-delta T cells in the human immune response to cytomegalovirus Dechanet, Julie
1999
12 2 p. 137-
1 p.
artikel
109 Importance of pp67 mRNA-detection and CMV-DNA quantification in HIV-infected patients Kaiser, Rolf
1999
12 2 p. 104-
1 p.
artikel
110 Induction of human cytomegalovirus (CMV) specific cytotoxic T lymphocyte and helper T cell responses in humans by a canarypox-CMV-phosphoprotein 65 (pp65) recombinant Berencsi, Klara
1999
12 2 p. 165-
1 p.
artikel
111 Induction of MCMV gene expression in latently infected macrophage progenitor cells by maturation stimuli Henry, Stanley
1999
12 2 p. 98-
1 p.
artikel
112 Induction or blocking of apoptosis by human cytomegalovirus infection is dependent on cellular lineage Suárez-Souto, María
1999
12 2 p. 119-
1 p.
artikel
113 Influence of the cell cycle on the initiation of the HCMV infection — How the virus beats the clock Spector, Deborah
1999
12 2 p. 90-
1 p.
artikel
114 Inhibition of CMV in vitro and in vivo by the experimental immunosuppressive agent leflunomide Waldman, W.James
1999
12 2 p. 174-
1 p.
artikel
115 Inhibition of HCMV replication by the tetrahydroindolizine CMV423 Snoeck, Robert
1999
12 2 p. 113-
1 p.
artikel
116 Inihibition of human cytomegalovirus replication by a phosphodiester antisense oligonucleotide carried by S-Gal-beta-cyclodextrin Abdou, Souad
1999
12 2 p. 109-
1 p.
artikel
117 Interaction of cytomegalovirus with endothelial cells Bruggeman, Cathrien
1999
12 2 p. 90-
1 p.
artikel
118 Interleukin-1 inhibits in vitro growth of CMV in human marrow stromal cells Randolph-Habecker, Julie
1999
12 2 p. 120-
1 p.
artikel
119 Interstrain variabilities of HCMV infection in various trophoblast models Halwachs-Baumann, Gabriele
1999
12 2 p. 121-
1 p.
artikel
120 Intragenic variability of human cytomegalovirus glycoprotein H in clinical strains is due to genetic recombination Hufert, Frank
1999
12 2 p. 95-
1 p.
artikel
121 Investigation of an HCMV AD169 mutant lacking complete copies of genes UL42 and UL43 Dargan, Derrick
1999
12 2 p. 106-
1 p.
artikel
122 In vitro expression and enzyme activity analysis of mutant human cytomegalovirus DNA polymerases Alain, Sophie
1999
12 2 p. 109-
1 p.
artikel
123 In vitro generated human cytoemgalovirus (HCMV) pp65-antigenemia is mediated by microfusion events of polymorphonuclear leukocytes and wild-type virus-infected endothelial cells Revello, Maria Grazia
1999
12 2 p. 119-
1 p.
artikel
124 In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus Grzimek, Natascha
1999
12 2 p. 99-
1 p.
artikel
125 Lack of association between HCMV glycoprotein b (gb) genotypes in blood of AIDS patients and the viral DNA load in leukocytes or presence of HCMV retinitis Boivin, Guy
1999
12 2 p. 133-
1 p.
artikel
126 Latency and myeloid cells Mocarski, Edward S.
1999
12 2 p. 85-
1 p.
artikel
127 Localization of genome differences between endotheliotropic and non-endotheliotropic strains of human cytomegalovirus Schmidt, Karin
1999
12 2 p. 155-
1 p.
artikel
128 Low anti-HCMV IgG level as a consequence of transient hypogammaglobulinemia in infected premature infants Milewska-Bobula, Bogumila
1999
12 2 p. 143-
1 p.
artikel
129 Low or null cytotoxic activity by nk cells to human cytomegalovirus infected cells Chacón-Salinas, Rommel
1999
12 2 p. 131-
1 p.
artikel
130 MCMV tropism for the auditory nervous system in SCID mice Woolf, Nigel
1999
12 2 p. 162-
1 p.
artikel
131 Mechanism of interferon-gamma (IFNγ) action during acute and latent murine cytomegalovirus (MCMV) infection Virgin, Herbert
1999
12 2 p. 85-
1 p.
artikel
132 Meeting-at-a-glance 1999
12 2 p. 77-
1 p.
artikel
133 MHC class I regulatory genes of CMV. Are they pathogenicity genes? Koszinowski, Ulrich
1999
12 2 p. 89-
1 p.
artikel
134 Model to differentiate cytomegalovirus diseases and rejection episodes in organ transplantation Müller, Thomas
1999
12 2 p. 136-
1 p.
artikel
135 Modifications of chemokine production and the cytoskeleton in human cytomegalovirus (CMV) infected bone marrow stromal cells Michelson, Susan
1999
12 2 p. 126-
1 p.
artikel
136 Modulation of IL-8 and Rantes production by bone marrow stromal cells during human cytomegalovirus (HCMV) infection Lagneaux, Laurence
1999
12 2 p. 157-
1 p.
artikel
137 Monitoring cytomegalovirus mRMA expression in blood leukocytes of liver transplant patients using nucleic acid sequence-based amplification (NASBA) Blok, Rien
1999
12 2 p. 178-
1 p.
artikel
138 Most post-transplant CMV reactivations are symptomatic and have to be treated with antivirals Lautenschlager, Irmeli
1999
12 2 p. 171-
1 p.
artikel
139 Mouse cytomegalovirus (MCMV) replication strictly depends on the interferon-inducible lfi200 genes Landolfo, Santo
1999
12 2 p. 96-
1 p.
artikel
140 Murine cytomegalovirus replication in salivary glands is controlled by perforin, granzyme A and granzyme B during acute infection Riera, Ludovica
1999
12 2 p. 141-
1 p.
artikel
141 Performance of a novel combination of recombinant antigens for the detection of CMV IgG antibodies in key diagnostic populations Tirrell, Stephen
1999
12 2 p. 148-
1 p.
artikel
142 Phosphorylation regulates the activity of HCMV immediate early protein IE72 Himmelheber, Chris
1999
12 2 p. 123-
1 p.
artikel
143 Polymerase chain reaction monitoring, and prophylaxis of cytomegalovirus (CMV) infection after bone marrow transplantation (BMT) Costa, Sandra
1999
12 2 p. 167-
1 p.
artikel
144 Potential use of human cytomegalovirus immediate-early mRNA detection by NASBA for monitoring of antiviral treatment in bone marrow transplant recipients Lilleri, Daniele
1999
12 2 p. 172-
1 p.
artikel
145 Potent inhibition of human cytomegalovirus (HCMV) replication by alkenyl guanine analogs with a thiazole[4,5-d]pyrimidine ring Neyts, Johan
1999
12 2 p. 111-
1 p.
artikel
146 Predictive value of peripheral blood leukocytes (PBL) cytomegalovirus (CMV) quantification by PCR assay on occurrence of CMV disease as compared to others CMV blood markers in HIV infected patients under HAART included in the predivir cohort (ANRS EP7) Fillet, Anne-Marie
1999
12 2 p. 182-
1 p.
artikel
147 Prevalence of the IE1-exon 4-specific CTL in naturally seropositive healthy individuals Burian, Katalin
1999
12 2 p. 141-
1 p.
artikel
148 Pro- and anti-inflammatory cytokines during human CMV infection Nordøy, Ingvild
1999
12 2 p. 135-
1 p.
artikel
149 Productive, lytic infection of human aortic endothelial cells by endotheliotropic HCMV isolates Kahl, Martina
1999
12 2 p. 155-
1 p.
artikel
150 Quantitation of CMV in Semen by hybrid capture CMV DNA assay McMullen, Dragana
1999
12 2 p. 102-
1 p.
artikel
151 Quantitative PCR in the follow-up of CMV infected allogeneic bone marrow recipients Mengelle, Catherine
1999
12 2 p. 180-
1 p.
artikel
152 Rapid identification of essential and nonessential cytomegalovirus genes by direct transposon mutagenesis Brune, Wolfram
1999
12 2 p. 93-
1 p.
artikel
153 Real time HCMV DNA quantification in plasma Schmidt, Christian Andreas
1999
12 2 p. 181-
1 p.
artikel
154 Recombinant GFP-expressing human cytomagalovirus as a tool to screen for putative antivirals Marschall, Manfred
1999
12 2 p. 114-
1 p.
artikel
155 Recombinant viral antigens for the detection of human cytomagalovirus (HCMV) IgM in sera from transplanted patients: comparison with the antigenemia test and conventional IgM serology Ghisetti, Valeria
1999
12 2 p. 114-
1 p.
artikel
156 Recovery of antibody responses to cytomegalovirus glycoprotein B following highly active antiretroviral therapy Deayton, Jane
1999
12 2 p. 147-
1 p.
artikel
157 Replication-defective mutants of mouse cytomegalovirus elicit protective immunity Sweet, Clive
1999
12 2 p. 163-
1 p.
artikel
158 Retrospective analysis of human cytomegalovirus (HCMV) glycoprotein B genotypes in immunocompromised patients Costa, Fernando
1999
12 2 p. 168-
1 p.
artikel
159 Routine use of positive controls in the daily performance of the human cytomegalovirus antigenemia assay Percivalle, Elena
1999
12 2 p. 184-
1 p.
artikel
160 Scientific programme 1999
12 2 p. 78-84
7 p.
artikel
161 Sensitivity of pp65 antigen test in bronchoalveolar lavage (BAL) for detection of CMV pneumonitis in HIV patients Arasteh, Keikawus
1999
12 2 p. 173-
1 p.
artikel
162 Serologic studies on the clinical manifestation of CMV infection Kawaklova, Liliana
1999
12 2 p. 146-
1 p.
artikel
163 Simultaneous infection of healthy people with multiple human cytomegalovirus strains Meyer-König, Ursula
1999
12 2 p. 95-
1 p.
artikel
164 Specific and non-specific inhibition of CMV by a phosphorothioate oligonucleotide targeted to the pac-1 region of the a-sequence Zaia, John
1999
12 2 p. 115-
1 p.
artikel
165 Specific T-cell reactivity to HCMV derived peptides in HCMV seronegative individuals Kopp, Helena
1999
12 2 p. 134-
1 p.
artikel
166 Sustained disappearance of human cytomegalovirus (HCMV) DNA in blood of HIV-infected patients after 2 years of HAART Baldanti, Fausto
1999
12 2 p. 177-
1 p.
artikel
167 Sympathetic hyperactivity stimulates HCMV activation in monocytic cells Proesch, Susanna
1999
12 2 p. 96-
1 p.
artikel
168 The cytomegalovirus maturational proteinase Gibson, Wade
1999
12 2 p. 87-
1 p.
artikel
169 The early-late transcribed US28 exhibit sequence deviations in clinical isolates Minisini, Rosalba
1999
12 2 p. 153-
1 p.
artikel
170 The HCMV beta chemokine receptor homolog, US28, acts as a “chemokine sink” by binding endogenously and exogenously produced beta chemokines Randolph-Habecker, Julie
1999
12 2 p. 138-
1 p.
artikel
171 The human cytomegalovirus major 2.7kb early RNA interacts with a cellular polyA binding protein and regulates viral and cellular mRNA translation Sinclair, John
1999
12 2 p. 129-
1 p.
artikel
172 The humoral immune response against HCMV in T-cell-depleted (in vivo/ex vivo) allogeneic bone marrow transplant recipients Kroemer, Michael
1999
12 2 p. 139-
1 p.
artikel
173 The humoral immune response against human cytomegalovirus (CMV)- specific nonstructural proteins after kidney transplantation Potehin, Oleg
1999
12 2 p. 146-
1 p.
artikel
174 The major component pp43 of human cytomegalovirus @ iHCMVj UL112-113 gene products transactivates IE2-dependently or independently the HCMV UL54 promoter through two functional domains of pp43 Hirai, Kanji
1999
12 2 p. 101-
1 p.
artikel
175 The mouse cytomegalovirus m152 gene product mediates evasion from immune control through MHC class I restricted T lymphocytes in vivo Krmpotic, Astrid
1999
12 2 p. 140-
1 p.
artikel
176 The murine CMV chemokine homologue m131 is a determinant of virus pathogenicity Shellam, Geoffrey
1999
12 2 p. 158-
1 p.
artikel
177 The production and sequestering of the CC chemokine, MCP-1, by CMV infected endothelial cells: Effects on monocyte transmigration Yong, Kwee
1999
12 2 p. 132-
1 p.
artikel
178 Therapy of congenital cytomegalovirus infections Whitley, Richard
1999
12 2 p. 92-
1 p.
artikel
179 The role of cellular transcription factors in the control of latency and reactivation of human cytomegalovirus (HCMV) Bain, Mark
1999
12 2 p. 103-
1 p.
artikel
180 The role of hygiene in the prevention of cytomegalovirus transmission among children and adults in child care centers Murph, Jody
1999
12 2 p. 168-
1 p.
artikel
181 The use of an organ culture model of the saphenous vein to study cytomegalovirus infection of the vessel wall Olufeso, Femi
1999
12 2 p. 157-
1 p.
artikel
182 Towne/Toledo vaccine development Spaete, Richard
1999
12 2 p. 91-
1 p.
artikel
183 Transcription of the human cytomegalovirus natural killer decoy gene, UL18, in vitro and in vivo Hassan-Walker, Aycan
1999
12 2 p. 159-
1 p.
artikel
184 Treatment strategies for the immunocompromised host Einsele, Hermann
1999
12 2 p. 92-
1 p.
artikel
185 UL97 sequence variation of multiple post mortem tissues from AIDS patients following ganciclovir therapy Shannon-Lowe, Claire
1999
12 2 p. 185-
1 p.
artikel
186 UL18 surfacing? The human cytomegalovirus MHC class I homologue expressed in a hyper-glycosylated form Tomasec, Peter
1999
12 2 p. 128-
1 p.
artikel
187 Use of the SCID-hu retinal implant model for identifying virulence markers of human cytomegalovirus Bidanset-Ponder, Deborah
1999
12 2 p. 97-
1 p.
artikel
188 Value of immunoassay using Copalis ∗ (coupled particle light scattering) technology to set up cytomegalovirus (CMV) infection stages Mazeron, Marie-Christine
1999
12 2 p. 144-
1 p.
artikel
189 Viral dynamics of cytomegalovirus infection in solid organ transplant recipients Sia, Irene
1999
12 2 p. 170-
1 p.
artikel
190 Viral load and non lactoferrin concentrations in breast milk is predictive for the transmission of human cytomegalovirus to preterm neonates Van Der Strate, Barry
1999
12 2 p. 161-
1 p.
artikel
191 Virus burden in early infancy as a predictor of outcome in congenital CMV infection Boppana, Suresh
1999
12 2 p. 179-
1 p.
artikel
                             191 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland